Determinants of immunodominance for CD4 T cells

Research output: Contribution to journalArticle

Abstract

The term immunodominance was originally defined as a restricted T cell response to a short peptide sequence derived from a given protein [1]. The question of what determines immunodominance has been a longstanding battle for the past two decades. Hundreds of papers have been written on different aspects of epitope selection during antigen processing documenting the complexity of the process. Antigen processing machinery involves several accessory molecules and chaperons coevolved with proteins of Major Histocompatibility Complex (MHC) molecules that each plays its part in epitope selection. These molecules are targeted to specialized vesicular compartments that also accommodate antigen processing enzymes called cathepsins. Within the antigen processing compartments, highly regulated pH gradient and reducing conditions and enzymes necessary for denaturation of the antigens are available and function to optimize processing of antigen and selection of the fittest for transport to the cell membrane and presentation to T cells. Despite the complexity, a cell free reductionist antigen processing system was recently reported that included only few purified proteins, but was shown to process and select physiologically relevant epitopes from full length protein antigens [2••]. Due to its minimalist nature the system has been quite helpful in dissecting the factors that contribute to epitope selection during antigen processing. In this review, we would summarize and highlight models that may explain how the dominant epitope may be selected for presentation to CD4+ helper T cells.

Original languageEnglish (US)
Pages (from-to)9-15
Number of pages7
JournalCurrent Opinion in Immunology
Volume34
DOIs
StatePublished - Jun 1 2015

Fingerprint

Antigen Presentation
T-Lymphocytes
Epitopes
Proteins
Antigens
Enzymes
Cathepsins
Proton-Motive Force
Helper-Inducer T-Lymphocytes
Major Histocompatibility Complex
Cell Membrane
Peptides

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Determinants of immunodominance for CD4 T cells. / Kim, AeRyon; Sadegh-Nasseri, Scheherazade.

In: Current Opinion in Immunology, Vol. 34, 01.06.2015, p. 9-15.

Research output: Contribution to journalArticle

Kim, AeRyon; Sadegh-Nasseri, Scheherazade / Determinants of immunodominance for CD4 T cells.

In: Current Opinion in Immunology, Vol. 34, 01.06.2015, p. 9-15.

Research output: Contribution to journalArticle

@article{28ce21266984432ab15840755dacb22c,
title = "Determinants of immunodominance for CD4 T cells",
abstract = "The term immunodominance was originally defined as a restricted T cell response to a short peptide sequence derived from a given protein [1]. The question of what determines immunodominance has been a longstanding battle for the past two decades. Hundreds of papers have been written on different aspects of epitope selection during antigen processing documenting the complexity of the process. Antigen processing machinery involves several accessory molecules and chaperons coevolved with proteins of Major Histocompatibility Complex (MHC) molecules that each plays its part in epitope selection. These molecules are targeted to specialized vesicular compartments that also accommodate antigen processing enzymes called cathepsins. Within the antigen processing compartments, highly regulated pH gradient and reducing conditions and enzymes necessary for denaturation of the antigens are available and function to optimize processing of antigen and selection of the fittest for transport to the cell membrane and presentation to T cells. Despite the complexity, a cell free reductionist antigen processing system was recently reported that included only few purified proteins, but was shown to process and select physiologically relevant epitopes from full length protein antigens [2••]. Due to its minimalist nature the system has been quite helpful in dissecting the factors that contribute to epitope selection during antigen processing. In this review, we would summarize and highlight models that may explain how the dominant epitope may be selected for presentation to CD4+ helper T cells.",
author = "AeRyon Kim and Scheherazade Sadegh-Nasseri",
year = "2015",
month = "6",
doi = "10.1016/j.coi.2014.12.005",
volume = "34",
pages = "9--15",
journal = "Current Opinion in Immunology",
issn = "0952-7915",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Determinants of immunodominance for CD4 T cells

AU - Kim,AeRyon

AU - Sadegh-Nasseri,Scheherazade

PY - 2015/6/1

Y1 - 2015/6/1

N2 - The term immunodominance was originally defined as a restricted T cell response to a short peptide sequence derived from a given protein [1]. The question of what determines immunodominance has been a longstanding battle for the past two decades. Hundreds of papers have been written on different aspects of epitope selection during antigen processing documenting the complexity of the process. Antigen processing machinery involves several accessory molecules and chaperons coevolved with proteins of Major Histocompatibility Complex (MHC) molecules that each plays its part in epitope selection. These molecules are targeted to specialized vesicular compartments that also accommodate antigen processing enzymes called cathepsins. Within the antigen processing compartments, highly regulated pH gradient and reducing conditions and enzymes necessary for denaturation of the antigens are available and function to optimize processing of antigen and selection of the fittest for transport to the cell membrane and presentation to T cells. Despite the complexity, a cell free reductionist antigen processing system was recently reported that included only few purified proteins, but was shown to process and select physiologically relevant epitopes from full length protein antigens [2••]. Due to its minimalist nature the system has been quite helpful in dissecting the factors that contribute to epitope selection during antigen processing. In this review, we would summarize and highlight models that may explain how the dominant epitope may be selected for presentation to CD4+ helper T cells.

AB - The term immunodominance was originally defined as a restricted T cell response to a short peptide sequence derived from a given protein [1]. The question of what determines immunodominance has been a longstanding battle for the past two decades. Hundreds of papers have been written on different aspects of epitope selection during antigen processing documenting the complexity of the process. Antigen processing machinery involves several accessory molecules and chaperons coevolved with proteins of Major Histocompatibility Complex (MHC) molecules that each plays its part in epitope selection. These molecules are targeted to specialized vesicular compartments that also accommodate antigen processing enzymes called cathepsins. Within the antigen processing compartments, highly regulated pH gradient and reducing conditions and enzymes necessary for denaturation of the antigens are available and function to optimize processing of antigen and selection of the fittest for transport to the cell membrane and presentation to T cells. Despite the complexity, a cell free reductionist antigen processing system was recently reported that included only few purified proteins, but was shown to process and select physiologically relevant epitopes from full length protein antigens [2••]. Due to its minimalist nature the system has been quite helpful in dissecting the factors that contribute to epitope selection during antigen processing. In this review, we would summarize and highlight models that may explain how the dominant epitope may be selected for presentation to CD4+ helper T cells.

UR - http://www.scopus.com/inward/record.url?scp=84920683669&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920683669&partnerID=8YFLogxK

U2 - 10.1016/j.coi.2014.12.005

DO - 10.1016/j.coi.2014.12.005

M3 - Article

VL - 34

SP - 9

EP - 15

JO - Current Opinion in Immunology

T2 - Current Opinion in Immunology

JF - Current Opinion in Immunology

SN - 0952-7915

ER -